The global catalog peptides market attained a value of $238.4 million in 2018 and is predicted to progress at a CAGR of 5.8% between 2019 and 2024. Furthermore, based on the estimates of the market research firm, P&S Intelligence, the market is expected to reach a valuation of $332.1 million by 2024. The major factors driving the surge of the market are the soaring number of research and development (R&D) activities in several therapeutic applications, increasing incidence of chronic diseases, and surging investments in protein-based research.